Merz Pharmaceuticals is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.
Trademark Applications
Trademark applications show the products and services that Merz Pharmaceuticals is developing and marketing.
Merz Pharmaceuticals doesn't have any recent trademark applications, indicating Merz Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SKIN CARE FOR SCARS Pharmaceutical preparations for use in dermatology; pharmaceutical preparations namely a gel, cream or ointment designed to improve the appearance of scars, blemishes and other skin imperfections
04/27/2018
SKIN CARE FOR SCARS MEDERMA Pharmaceutical preparations for use in dermatology; pharmaceutical preparations namely a gel, cream or ointment designed to improve the appearance of scars, blemishes and other skin imperfections
04/27/2018
CUVPOSA Pharmaceutical preparations for use in the treatment of sialorrhea
07/07/2010
See all trademarks and details in the Full Report.
Market Share of Merz Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Merz Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Merz Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Merz Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.